Clinics and Research in Hepatology and Gastroenterology

Papers
(The TQCC of Clinics and Research in Hepatology and Gastroenterology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Acute liver failure: Beyond the guidelines, the challenge of liver support therapies66
Therapeutic benefit of probiotic in alcohol dependence syndrome: Evidence from a tertiary care centre of India45
Neighborhood opportunity is associated with completion of hepatocellular carcinoma surveillance prior to the diagnosis of hepatocellular carcinoma in patients with cirrhosis41
ARHGEF39 targeted by E2F1 fosters hepatocellular carcinoma metastasis by mediating fatty acid metabolism39
Pathological complete response of liver metastases of cholangiocarcinoma using hepatic intra-arterial gemcitabine-oxaliplatin38
An unusual endoscopic appearance of mantle cell lymphoma37
The efficacy of adjuvant N acetyl cysteine for the eradication of H pylori infections: A systematic review and meta-analysis of randomized clinical trials35
Contents33
Residential proximity to pesticide-treated farmland is associated with elevated liver enzymes32
Editorial board31
Suicide risk is elevated among patients with chronic liver disease and cirrhosis in the United States31
Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population30
Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic Review and Meta-Analysis27
Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease27
Effects of saroglitazar in the treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis24
The synergistic therapeutic effect of imatinib and protein kinase CK2 Inhibition correlates with PI3K-AKT activation in gastrointestinal stromal tumors24
Incidence and risk factors for rebleeding after emergency endoscopic hemostasis for marginal ulcer bleeding24
Neonatal jaundice caused by compound mutations of SLC10A1 and a novel UGT1A1 gene23
Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric inpatients22
Effects of continuous venous-venous hemofiltration with or without hemoperfusion on patients with hypertriglyceride acute pancreatitis22
Gastric xanthelasma: A rare cause of gastrointestinal bleeding22
Crigler Najjar syndrome type II with severe jaundice as a new subtype(?) : A rare case report22
Hepatitis B virus-associated hepatocellular carcinoma with invasion into right atrium22
Sustained response and HBsAg loss after nucleo(s)tide analogue discontinuation in chronic hepatitis B patients: the prospective SNAP study20
An incidental hepatic lesion in a cirrhotic liver20
Non-invasive diagnosis and follow-up of primary sclerosing cholangitis20
Elevated LINC01232 is associated with poor prognosis and HBV infection in hepatocellular carcinoma patients and contributes to tumor progression in vitro18
Partial splenectomy in children undergoing liver transplantation or venous shunt for severe hypersplenism: A case control comparative study18
Sorafenib-induced liver failure in a hepatocellular carcinoma patient: Letter to the editor18
Multifocal nodular fatty infiltration of the liver: A donut-shaped appearance18
The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound17
A novel homozygous mutation, c.662_672del, in DGUOK gene causing mitochondrial DNA depletion syndrome of type hepatocerebral – A case report17
Spontaneous bacterial peritonitis caused by Listeria monocytogenes: A rare infection with very high leukocyte counts in ascitic fluid–case report and review of the literature17
Relationship between interferon-induced transmembrane protein 3 and matrix metalloproteinase-9 gene polymorphisms in patients with hepatocellular carcinoma17
Efficacy of robot-assisted vs. laparoscopy surgery in the treatment of colorectal cancer: A systematic review and meta-analysis16
Gastrointestinal Angiectasia in patients with chronic kidney disease: A matched case-control study16
Improving colorectal cancer screening - consumer-centred technological interventions to enhance engagement and participation amongst diverse cohorts16
Involvement of oxidative stress, lipid dysmetabolism and gut microbiol dysbiosis in oxaliplatin-induced fatty liver disease: evidence from a tree shrew model16
High incidence of hepatocarcinoma in patients with advanced fibrosis treated with direct-acting antiviral agents for hepatitis C: A real-world retrospective study16
Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-1916
Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study16
Liver fibrosis evaluation in patients with psychiatric diseases15
The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience15
Contents14
Selenium inhibits ferroptosis in ulcerative colitis through the induction of Nrf2/Gpx414
Editorial board14
The pan immune inflammatory value in relation to non-alcoholic fatty liver disease and hepatic fibrosis14
Thromboembolism and bleeding in patients with atrial fibrillation and liver disease – A nationwide register-based cohort study13
Predictive factors of spontaneous common bile duct clearance and unnecessary ERCP in patients with choledocholithiasis13
An unusual mass in the colon: Inflammatory myofibroblastic tumor13
Hypercholanaemia from sodium-taurocholate cotransporting polypeptide deficiency in pregnancy13
A novel XIAP mutation in an adult Chinese patient with refractory Crohn's disease13
Contents13
Hepatic steatosis leads to overestimation of liver stiffness measurement in both chronic hepatitis B and metabolic-associated fatty liver disease patients13
Editorial board13
Editorial board13
Editorial board13
MAdCAM-1 does not play a central role in the early pathophysiology of autoimmune hepatitis12
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC12
The impact of secondhand smoke on failure of Helicobacter pylori therapy is not inferior to that of smoking12
Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials12
Primary gastrointestinal follicular lymphoma12
Metabolic-associated fatty liver disease and the risk of cardiovascular disease12
Optimization of endoscopic treatment strategies for R0 resection of rectal neuroendocrine tumors smaller than 10 mm12
Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus11
Non-invasive diagnosis and follow-up of chronic liver disease11
Cardiac metastasis of colorectal cancer: a case report and review of literature11
FXR contributes to obstructive jaundice-induced vascular hyporeactivity in mesenteric arteries by reconstituting BKCa channels11
Factors influencing pathological changes in the liver tissue in hepatitis B virus carriers with low-level viremia11
Rifaximin for Primary prophylaxis of Overt Hepatic Encephalopathy After Transjugular intrahepatic portosystemic shunt: A Cohort Analysis11
Hereditary diffuse gastric cancer (HDGC). An overview11
Porto-sinusoidal vascular disorder, report of a novel association with POEMS syndrome. Future challenge for the hepatologist11
Modified Zhizhu Pill improves the loperamide-induced slow transit constipation via gut microbiota and neurotransmitters in microbiota-gut-brain axis11
The function of long non-coding RNA in non-alcoholic fatty liver disease11
Dependent functional status is an independent risk factor for 30-day mortality and morbidities following colectomy for volvulus: An ACS-NSQIP study from the United States11
A class of MicroRNAs as diagnostic biomarkers and therapeutic strategies in non-alcoholic fatty liver disease: A review11
Thermal ablation for hepatic tumors in high-risk locations10
Aberrant expression of the esophageal carcinoma related gene 4 as a prognostic signature for hepatocellular carcinoma10
Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case report10
Cap pressure characterization and band ligation for a tiny duodenal angioectasia with acute feeding vessel bleeding mimicking a Dieulafoy lesion10
Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-1910
Intentional R1 resection of liver metastases: A new treatment paradigm for patients with advanced colorectal cancer based on a propensity score–Matched case-control analysis10
BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma10
lncRNA TM4SF1-AS1 predicts dismal outcomes and promotes cholangiocarcinoma progression via modulating miR-744-3p9
Access to care and the Hispanic paradox among Hispanic patients with hepatocellular carcinoma9
Lichenoid eruption during antiPD-L1 immunotherapy with avelumab in metastatic colorectal cancer9
Adherent-invasive E. coli (AIEC) in Crohn’s disease: where are we in 2025? Tribute to Professor Nicolas Barnich9
Ribavirin-resistant chronic norovirus infection-associated enteropathy in common variable immunodeficiency. Case report and review of the literature9
Non-invasive diagnosis and follow-up of primary malignant liver tumours9
New findings and advice for resmetirom9
Discontinuing directly acting antivirals during hepatitis C treatment: highlighting an infrequent but hostile event9
The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review.9
Editorial board9
Catching the STING: Unlocking senescence and PD-L1 in PBC9
Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor9
Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer9
Association of mitotic checkpoint regulator MAD2L1 with fibrosis progression in chronic hepatitis C patients9
Non-bioartificial artificial liver support system in acute liver failure: A comprehensive systematic review and meta-analysis of randomized controlled trials9
Editorial board8
Indigo naturalis (Qing dai) for inflammatory bowel disease: A systematic review and meta-analysis8
The efficacy and safety of budesonide combined with azathioprine versus predniso(lo)ne combined with azathioprine for autoimmune hepatitis: A systematic review and meta-analysis8
The role of tumor microenvironment in lenvatinib resistance of hepatocellular carcinoma8
Efficacy and safety of dapagliflozin compared to pioglitazone in diabetic and non-diabetic patients with non-alcoholic steatohepatitis: A randomized clinical trial8
Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyo8
Long-term risk of inflammatory bowel disease in autoimmune hepatitis: Over a 20-year population-based study8
MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer8
A novel mutation in TRMT5 associated with idiopathic non-cirrhotic portal hypertension and hepatopulmonary syndrome: Case report of two siblings8
An unusual case of diarrhea: Autoimmune enteropathy8
Clinical significance of ribosome production factor 2 homolog in hepatocellular carcinoma8
Endoscopic submucosal dissection for early esophageal squamous cell carcinoma after ligation and sclerotherapy of esophageal and gastric varices8
Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer8
Contents8
Superiority of frailty over age in predicting outcomes among clostridium difficile patients: Evidence from national data8
Efficacy and safety of HER2-targeted therapy in patients with colorectal cancer: What should we expect from a meta-analysis?8
Factors associated with non-presentation in a multidisciplinary team meeting for colon cancer: A matched retrospective cohort study in a French area8
Clinical significance of LINC02532 in hepatitis B virus-associated hepatocellular carcinoma and its regulatory effect on tumor progression8
Curcumae longae Rhizoma (Jianghuang) extract reverses the 5-Fluoruracil resistance in colorectal cancer cells via TLR4/PI3K/Akt/mTOR pathway8
Portal-hepatic venous shunt in a patient with trisomy 218
Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-β-mediated fibrosis8
Hepatitis B and C in Pakistan: A silent crisis demanding urgent action8
Effectiveness of metformin for the reversal of cold-ischemia-induced damage in hepatosteatosis7
Contents7
Pathophysiology and management of enteric hyperoxaluria7
A superficial esophageal cancer with a Rokitansky diverticulum treated by endoscopic submucosal dissection with dental floss clip traction: Letter to the editor7
Kala-azar in solid organ transplant recipients, a case report and literature review. Ancient disease, old world, new patients7
Granulocyte colony stimulating factor in decompensated cirrhosis, acute alcoholic hepatitis, and acute-on-chronic liver failure: A comprehensive meta-analysis of randomized controlled trials7
Association of serum C-peptide with all-cause and cardiovascular disease mortality in ultrasound-defined nonalcoholic fatty liver disease7
Treatment response, survival, and safety profile of camrelizumab plus apatinib regimen as third-line treatment in metastatic gastric cancer patients7
Efficacy of gastric per-oral endoscopic myotomy remains similar after failure of interventional techniques in refractory gastroparesis7
TACE plus PD-1 successfully achieves conversion therapy for unresectable HCC with multiple macrovascular invasion: Case report7
Editorial board7
Sinomenine hydrochloride improves DSS-induced colitis in mice through inhibition of the TLR2/NF-κB signaling pathway7
Altered biliary microbial and metabolic profile reveals the crosstalk between NAFLD and cholelithiasis7
Editorial board7
The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury7
Refractory GERD and systemic sclerosis: The end of a dead end?7
Intra- and inter-patient diversity in hepatocellular carcinoma based on phosphorylation profiles—A pilot study in a single institution7
Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis7
Clinicopathological characteristics of crawling-type gastric adenocarcinoma7
DRESS syndrome associated with a hemophagocytic lympho-histiocytosis: A rare presentation of DILI induced by a nutritional supplement7
Lower gastrointestinal bleeding from colonic varices of unknown origin7
Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis7
Long-term antibody response to inactivated SARS-CoV-2 vaccination in patients with chronic liver disease: A multicenter study7
Impact of sedation type on adenoma detection rate by colonoscopy7
Evaluation of osteoporosis in adult patients with beta-thalassemia major and its relation to serum sclerostin level7
Massive peritoneal tumoral dissemination after hepatocellular carcinoma percutaneous microwave ablation with intraperitoneal CO2 insufflation7
Aging affects FIB-4 index in the general population without pre-existing diseases: Analysis of a cohort of healthy individuals who underwent annual health checkups for 10 consecutive years6
A retracted diagnosis-when liver capsule retraction is not what it seems6
Fatal outcome of erythropoietic protoporphyria with advanced liver disease6
Innovative wide-field superficial en bloc R0 resection of a unique colorectal high-grade dysplasia: "horizontal full-thickness resection"6
Opportunistic fast-track sub-submerged true underwater endoscopic mucosal resection (uEMR) for a gravity-sided rectal lesion during screening colonoscopy6
Applying proteomics in metabolic dysfunction-associated steatotic liver disease: From mechanism to biomarkers6
The smoker's paradox in transjugular intrahepatic portosystemic shunt procedure: A national inpatient sample analysis from 2015 to 20206
Fecal incontinence subtype assessment (FI-SA): A new tool to distinguish among subtypes of fecal incontinence in a neurogenic population6
Individual and population screening of varices needing treatment by a simple, safe and accurate test6
Clinical benefit of statin treatment on patients with non-alcoholic fatty liver disease or steatohepatitis6
Hepatic organoids as a platform for liver disease modeling and the development of novel therapies6
Proton pump inhibitors versus H2-receptor antagonists in cirrhotic patients: A clinical case and literature perspective6
Physiology-guided albumin therapy in decompensated cirrhosis: the expanding role of point-of-care ultrasound6
A wandering spleen6
Transjugular Intrahepatic Portosystemic Shunt is effective to treat portal hypertension due to sinusoidal obstructive syndrome6
Editorial board6
An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis6
The risk of diabetes mellitus in patients with post-ERCP pancreatitis—A preliminary report6
Associations of advanced therapies in inflammatory bowel diseases6
Diagnostic yield of repeat genetic testing in idiopathic chronic pancreatitis6
Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study6
A systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy5
Assessing the efficacy of farnesoid X receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis5
Endoscopic features of low-phospholipid-associated cholelithiasis syndrome: A retrospective cohort study5
Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression5
Chronic enteropathy associated with SLCO2A1-associated primary hypertrophic osteoarthropathy in a female patient5
Correspondence on “Evaluation of long-term changes in liver function and structure in patients exposed to SARS-CoV-2 infection: a prospective study”5
Management of portal hypertension in patients with hepatocellular carcinoma5
Long non-coding RNA plasmacytoma variant translocation 1 correlates with higher inflammation, multiple organ injury and mortality risk in acute pancreatitis, especially in severe acute pancreatitis5
Effectiveness of mobile health intervention for non alcoholic fatty liver disease- A meta analysis of randomized controlled trials5
Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis5
White adipose tissue in metabolic associated fatty liver disease5
Prevalence and impact of sarcopenia in patients with inflammatory bowel diseases: A prospective cohort study5
Editorial board5
Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals5
Number of bottles of esophageal biopsies in the evaluation of eosinophilic esophagitis and clinical outcomes5
Thirty-day outcomes of non-emergent colectomy for inflammatory bowel disease in patients with chronic obstructive pulmonary disease5
Contents5
Transarterial chemoembolization (TACE) plus apatinib-combined therapy versus TACE alone in the treatment of intermediate to advanced hepatocellular carcinoma patients: A real-world study5
Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria: A single-center propensity score matching analysis5
Prevalence of depression among patients with chronic pancreatitis: A systematic review and meta-analysis5
Contents5
NAFLD: genetics and its clinical implications5
Comparison of rectal indomethacin and diclofenac for post ERCP pancreatitis prophylaxis: A single center study5
Analgesics use and risk of pancreatitis: Result from the UK Biobank5
Development of a cross-species model to predict clinical outcomes based on efficacy in mouse models of non-alcoholic fatty liver disease5
A simple cap-assistant method to removal fishbone embedded in the cervical esophageal wall5
Does the benefit of optimal MASH treatment depend on a reduction in myosteatosis?5
Eosinophilic oesophagitis: Significantly increasing prevalence in a tertiary London paediatric gastro-intestinal and allergy department5
Ciliated hepatic foregut cyst: An uncommon cystic liver lesion5
The diagnostic performance of serum αvβ6 autoantibodies for ulcerative colitis: A systematic review and meta-analysis5
Methylation profile of CD247 and FOXP3 genes and frequency of certain HLA-DQ haplotypes in Celiac disease5
Contents4
Abstinence is associated with better outcomes in patients with alcohol-related hepatocellular carcinoma: Results of an observational study4
Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus4
Evaluation of a nutritional education guide designed for patients living with cirrhosis: A randomized controlled mixed-methods study4
Association between prior appendectomy and the risk and course of Crohn's disease: A systematic review and meta-analysis4
Glutamine synthetase and hepatocellular carcinoma4
Nodular gastric antral vascular ectasia: Distinct portal hypertensive hyperplastic polyp lesions4
Focal loss of mural stratification as a radiological predictor for small bowel adenocarcinoma in Crohn's disease4
Syphilitic granulomatous hepatitis4
Granulomatosis with Polyangiitis with colon involvement as a mimicker of Crohn's disease4
Nutrition support in pancreatic cancer: An expert statement on practical implementation of French guidelines4
Steatosis non-invasive tests accurately predict metabolic dysfunction-associated steatotic liver disease, while fibrosis non-invasive tests fall short: Validation in U.S. adult population4
Editorial board4
Higher risk of in-hospital mortality and hepatic encephalopathy during weekend admission in Transjugular Intrahepatic Portosystemic Shunt procedure4
“De novo” cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!4
Separating the effects of early and later life body mass index on liver diseases: A Mendelian randomization study4
Mixed neuroendocrine non-neuroendocrine neoplasm combining neuroendocrine tumor with hepatocellular carcinoma in the context of multiple endocrine neoplasia type 14
Gut dysbiosis in Crohn's disease: Never so close to solving the chicken-and-egg enigma: Commentary to “Gut microbiome composition is associated with future onset of Crohn's disease in healthy first-de4
Evaluation of long-term changes in liver function and structure in patients exposed to SARS-CoV-2 infection: A prospective study4
Safety and efficacy of dexmedetomidine vs. midazolam in complex gastrointestinal endoscopy: A systematic review and meta-analysis4
Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,4
Treatment patterns, risk factors and outcomes for patients with newly diagnosed hepatocellular carcinoma in France: A retrospective database analysis4
Advancements of direct oral anticoagulants in cirrhotic individuals with portal vein thrombosis4
Precision oncology in colorectal cancer: An anatomical revolution through molecular-clinical integration across colonic subsites4
Expert opinion on hot topics in the field of IBD4
Editorial board4
The detection rate of granulomas differs between intestinal segments and lesions in Chinese patients with Crohn's disease4
Women and liver: Is woman the future of man?4
Editorial board4
Contents4
Effectiveness of medical treatments depending on Crohn’s disease location. That is the question4
Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 20194
Natalizumab-induced autoimmune liver injury4
When cirrhosis meets paroxysmal nocturnal hemoglobinuria: What kind of “fireworks” scenario will occur?4
Development of a nomogram for postoperative surgical site infections in patients undergoing bowel resection for Crohn's disease4
Use of gastroscope for flexible sigmoidoscopy: A procedure at high risk of contamination which should be strictly controlled4
Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter study4
Comparison of sodium-glucose cotransporter-2 inhibitors and thiazolidinediones for management of non-alcoholic fatty liver disease: A systematic review and meta-analysis4
Endoscopic submucosal dissection versus endoscopic mucosal resection for early esophageal adenocarcinoma4
Association between metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction subtypes and risk of colorectal cancer: A prospective cohort study4
Exploring the relationship between vitamin D and hepatic carcinoma in individuals diagnosed with hepatitis B virus infection4
T lymphocyte-mediated pyroptosis: A new regulatory mechanism in non-viral liver disease4
Prophylactic sequential antibiotic therapy for recurrent liver/biliary sepsis4
Worse fibro-inflammatory activity on diagnostic liver biopsy adversely impacts biochemical remission in autoimmune hepatitis4
Cholangiopathy in sickle cell disease4
Adenosquamous intrahepatic cholangiocarcinoma in a patient with primary sclerosing cholangitis and ulcerative colitis4
Sodium taurocholate co-transporting polypeptide deficiency4
Evaluating the influence of maternal anti-HBs status on the antibody levels in vaccinated children4
Diagnosis and management of patients with Crohn’s disease. Position paper from the GETAID4
0.037769079208374